News

Article

NeurologyLive® Friday 5 — October 25, 2024

Key Takeaways

  • Updated stroke prevention guidelines focus on cardiovascular risk in women, sedentary behavior, and new treatments.
  • Approval of once-nightly sodium oxybate offers a new treatment option for pediatric narcolepsy.
SHOW MORE

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending October 25, 2024.

Welcome to NeurologyLive®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive®'s widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

1: Highlighting More Risk Factors and Treatments in Updated Stroke Prevention Guidelines: Cheryl D. Bushnell, MD, MHS, FAHA

The professor of neurology at Wake Forest University School of Medicine talked about how the newly updated stroke prevention guideline introduces recommendations addressing cardiovascular risk in women, sedentary behavior, and groundbreaking treatments. [WATCH TIME: 6 minutes]

Highlighting More Risk Factors and Treatments in Updated Stroke Prevention Guidelines: Cheryl D. Bushnell, MD, MHS, FAHA

2: Understanding the Approval of Once-Nightly Sodium Oxybate for Pediatric Narcolepsy: Anne Marie Morse, DO, FAASM

The director of Child Neurology and Pediatric Sleep Medicine at Geisinger Janet Weis Children's Hospital provided her immediate reaction to the approval of a once-nightly sodium oxybate for pediatric narcolepsy. [WATCH TIME: 7 minutes]

Understanding the Approval of Once-Nightly Sodium Oxybate for Pediatric Narcolepsy: Anne Marie Morse, DO, FAASM

3: New Treatment Guidelines for Restless Legs Syndrome and Shifting Away From Dopamine Agonists: John Winkelman, MD, PhD

The chief of the Sleep Disorders Clinical Research Program at Massachusetts General Hospital talked about the new clinical guidelines for treating restless legs syndrome which emphasize the risks of dopamine agonists and advocate for alternative therapies. [WATCH TIME: 8 minutes]

New Treatment Guidelines for Restless Legs Syndrome and Shifting Away From Dopamine Agonists: John Winkelman, MD, PhD

4: NeuroVoices: Lawrence Robinson, MD, on Innovating Educational Approaches for Neuromuscular Specialists

In our latest Q&A for NeuroVoices, the senior scientist at Sunnybrook Research Institute in Toronto, Ontario, provided clinical insight on his lecture given at AANEM 2024, focusing on the challenges and opportunities of teaching the next generation of practitioners.

NeuroVoices: Lawrence Robinson, MD, on Innovating Educational Approaches for Neuromuscular Specialists

5: How America's Neurological Care Crisis is Reshaping Medicare and What That Means for You

In a new submission, guest contributor Neal K. Shah, chief executive officer at CareYaya Health Technologies, talked about Medicare making big moves in neurological care.

How America's Neurological Care Crisis is Reshaping Medicare and What That Means for You

Related Videos
2 experts in this video
Michael Levy, MD, PhD, is featured in this series.
2 experts in this video
Alexander C. Whiting, MD
2 experts in this video
2 experts in this video
© 2024 MJH Life Sciences

All rights reserved.